Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Eledon Pharmaceuticals, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 121 | 2 | 161 | +42 |
| Shares | 42.6M | 9.97K | 46.9M | +4.27M (+10.0%) |
| Value | $131.2M | $30.7K | $184.6M | +$53.4M (+40.7%) |
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (51)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (9)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Jefferies Financial Group Inc. | 1,094,456 | $3.37M |
| Sanofi | 814,980 | $2.51M |
| SG Americas Securities, LLC | 635,845 | $1.96M |
| Stonepine Capital Management, LLC | 35,000 | $107.8K |
| Mitchell & Pahl Private Wealth, LLC | 30,000 | $92.4K |
| Forum Private Client Group LLC | 10,000 | $30.8K |
| Addison Advisors LLC | 1,300 | $4.00K |
| MAI Capital Management | 133 | $410 |
| Root Financial Partners, LLC | 110 | $339 |
Not filed for Q2 2026 yet (2)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 9,944 | $30.6K |
| Sunbelt Securities, Inc. | 26 | $80 |